Month: August 2022

Revenue increased 34% to $8.5 million in Q2 2022 vs. $6.3 million in Q2 2021; YTD revenue increased 31% to $17.2 million vs. $13.2 million in 2021 Operating income increased 127% to $1.1 million in Q2 2022 vs. $0.5 million in Q2 2021; YTD operating income increased 166% to $2.5 million in Q2 2022 vs. $1.0 million in 2021 Strengthened balance sheet via redemption of Series C preferred stock at discount New asset management agreement covering Anchor Portfolio provides expanded revenue opportunities and extends term through 2035 Dwight Schar, recently retired CEO/Chairman of NVR, Inc. (NYSE: NVR), joining Comstock as significant shareholderRESTON, Va., Aug. 15, 2022 (GLOBE NEWSWIRE) — Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock” or the “Company”) announced its financial results for the three and six months ended...

C$158.6 million in cash and short-term investments VANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (“Sabina”) or (the “Company”) (SBB – TSX/ SGSVF – OTCQX) reports the interim financial results for the quarter ended June 30, 2022. “The second quarter was extremely busy for the Company,” said Bruce McLeod, the Company’s President & CEO. “We continued with our procurement efforts, our civil works and advancing the underground exploration ramp. In addition, we completed a very successful exploration program with results continuing to demonstrate opportunities for delivery of higher-grade material earlier in the mine life. We have also focused on building our team with a major recruiting and hiring campaign as we prepare for full construction next year. The quarter culminated...

Company continues to add high-margin titles to growing content library VANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (NEO: AMEN) (OTC: AMNNF) (Frankfurt: 25YO), a global producer and distributor of independent movies, TV series and documentaries, announced today financial results for the three and six months ended June 30, 2022. All dollar amounts are in Canadian dollars unless otherwise stated. HighlightsGroup revenues for the six months ended June 30, 2022, were 6.0% ahead of the same comparable six-month period last year; EBITDA of $3,455,418 for the six months ended June 30, 2022, exceeded management budgets and fell just short of the same time period last year despite the impact of delays in production deliveries; Net income before translation adjustment...

On track for another record year in multiple business units NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES23% increase in revenue over the same period last year, reflecting higher patient volumes from the Company’s clinics, telehealth services, MCI Connect virtual healthcare services and the acquisitions of Khure Health (“Khure”) and the Polyclinic Group of Companies (“Polyclinic”) in 2021. Quarterly revenue of $13.8 million, on track for another record year in multiple business units. Polyclinic and Khure acquisitions performing well, with revenue growing over 500% for the rare disease data screening product anchored by Khure. Patient volumes up over 10% over the same period last year, excluding increases from acquisitions. Roll-out of the Company’s Data Insights as a Service offering, as the Company...

VANCOUVER, British Columbia, Aug. 15, 2022 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) reports its financial results for the six-month period ended June 30, 2022. All amounts are expressed in Canadian dollars, unless otherwise noted. This news release should be read together with Novo’s management’s discussion and analysis (the “MD&A”) and condensed interim consolidated financial statements (the “Financial Statements”) for the six-month period ended June 30, 2022 (“H1 2022”) which are available under Novo’s profile on SEDAR (www.sedar.com). The three-month period ended June 30, 2022 is referred to as “Q2 2022” in this news release. Q2 2022 HighlightsRevenue of $29.7 million from the sale of 12,378 ounces of gold from the Company’s Beatons Creek gold...

Omaha, Aug. 15, 2022 (GLOBE NEWSWIRE) — FitLife Brands Announces Preliminary Second Quarter 2022 Results and Hiring of New CFO OMAHA, NE – August 15, 2022 – FitLife Brands, Inc. (“FitLife” or the “Company”) (OTC PINK: FTLF), a provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition, PMD, SirenLabs, Nutrology, CoreActive, Metis Nutrition, iSatori, Energize, and BioGenetic Laboratories, today announced preliminary financial results for the three months ended June 30, 2022. The Company is providing the following preliminary update, not subject to any procedures by our independent registered public accounting firm, regarding its performance for the second quarter ended June 30, 2022 (unaudited):Total revenue is anticipated to be $7.9-8.1 million, of...

Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies. Field Trip Discovery renamed Reunion Neuroscience Inc. (“Reunion” or the “Company”), and will remain listed on the NASDAQ Stock Market and Toronto Stock Exchange under new ticker symbol “REUN”. Field Trip Health renamed Field Trip Health & Wellness Ltd. (“Field Trip H&W”) and has received listing approval from the Toronto Stock Exchange Venture under new ticker symbol “FTHW”. First day of trading for both Reunion and Field Trip H&W is August 17, 2022. On July 21, 2022, announced successful first dosings in the Company’s Phase 1 Clinical Study of its first novel psychedelic molecule, RE104 (formerly FT-104), being conducted in Australia. At June 30, 2022, the Company had approximately $52.3...